News
Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...
True or False: Pooled trial data showed that rheumatoid arthritis patients taking tofacitinib (Xeljanz) were less likely to gain weight. The FDA and CDC jointly recommended to pause use of the ...
COMMENT: Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes ...
Although the drugs help me shift unhealthy weight, I was then presented with an unexpected side effect, writes Charlotte ...
A 2023 test showing that Novo Nordisk (NYSE: NVO )’s Wegovy weight-loss medication not only helped people lose weight but ...
Novo Nordisk, the company that makes the weight loss drugs Ozempic and Wegovy, is abruptly ousting its chief executive, Lars Fruergaard Jørgensen, over concerns the firm is losing ground in the ...
17h
Yen on MSNOzempic-maker Novo Nordisk says CEO to step downDanish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...
11h
Best Life on MSNScientists Say This New Weight-Loss Pill Works Better Than Ozempic and Has No Side EffectsA Boston-based biopharmaceutical company is revolutionizing the weight-loss drug industry. Syntis Bio has created a daily ...
9h
DISABLED ENTREPRENEUR UK on MSNThe Weight Loss Drug Craze: Miracle Solution or Medical Risk?As weight loss injections dominate the headlines, many wonder whether these so-called miracle drugs are truly safe, what ...
May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results